Benzinga - Gainers
- Cerberus Cyber Sentinel Corporation (NASDAQ: CISO) shares rose 147% to $0.5682 in pre-market trading. Cerberus Cyber Sentinel said it sees Q4 revenue of $14.7 million and sees FY22 revenue of $46.5 million.
- Blue Star Foods Corp. (NASDAQ: BSFC) climbed 29.9% to $0.2061 in pre-market trading after jumping around 22% on Monday.
- Pear Therapeutics, Inc.. (NASDAQ: PEAR) gained 24.1% to $0.26 in pre-market trading after dropping 46% on Monday. Pear Therapeutics, last week, said it is exploring strategic alternatives and said it may seek a reorganization if it is unable to complete a transaction.
- First Republic Bank (NYSE: FRC) rose 20.6% to $14.69 in pre-market after dropping 47% on Monday. Jamie Dimon, CEO at JPMorgan Chase & Co. (NYSE: JPM), is leading talks with other leaders of prominent banks to resolve the First Republic crisis, the Wall Street Journal reported on Monday.
- Bird Global, Inc. (NYSE: BRDS) gained 17.6% to $0.13 in pre-market trading after declining 8% on Monday. Bird Global recently reported better-than-expected Q4 sales results.
- Catalyst Biosciences, Inc. (NASDAQ: CBIO) gained 16.6% to $0.22 in pre-market trading. GC Biopharma recently signed an Asset Purchase Agreement with the company.
- Aurora Innovation, Inc. (NASDAQ: AUR) shares rose 15.7% to $1.33 in pre-market trading after dropping around 9% on Monday.
- Selecta Biosciences, Inc. (NASDAQ: SELB) shares rose 14.1% to $1.46 in pre-market trading. Selecta Biosciences said Phase 3 DISSOLVE program of SEL-212 in chronic refractory gout met primary endpoint.
- Novo Integrated Sciences, Inc. (NASDAQ: NVOS) shares rose 13.4% to $0.1150 in pre-market trading.
- Edible Garden AG Incorporated (NASDAQ: EDBL) rose 11.2% to $4.11 in pre-market trading after gaining 14% on Monday. Edible Garden is scheduled to host a conference call on March 22, 2023 to discuss financial results for the quarter ended Dec. 31, 2022.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or
remove ads
.
Losers- Qutoutiao Inc. (NASDAQ: QTT) fell 64.2% to $0.25 in pre-market after gaining 3% on Monday.
- PainReform Ltd. (NASDAQ: PRFX) fell 23.8% to $0.4213 in pre-market trading. PainReform announced commencement of Phase 3 clinical trial to evaluate PRF-110 in patients undergoing bunionectomy surgery.
- First Majestic Silver Corp. (NYSE: AG) fell 17.1% to $6.17 in pre-market trading. First Majestic Silver temporarily suspended mining activities and reduced its workforce at Jerritt Canyon, which represented 21% of the company's 2022 revenue.
- Iveda Solutions, Inc. (NASDAQ: IVDA) shares dropped 12.8% to $0.95 in pre-market trading after gaining over 5% on Monday.
- Boxed, Inc. (NYSE: BOXD) fell 12.3% to $0.1202 in pre-market trading after jumping over 35% on Monday.
- Connect Biopharma Holdings Limited (NASDAQ: CNTB) fell 12.1% to $1.16 in pre-market trading after gaining 20% on Monday. Connect Biopharma announced post hoc data analysis from the Phase 2b CBP-201 global trial in moderate-to-severe atopic dermatitis (AD).
- ThermoGenesis Holdings, Inc. (NASDAQ: THMO) fell 11.7% to $3.93 in pre-market trading. ThermoGenesis closed $3 million private placement priced at-the-market under NASDAQ rules.
- Allarity Therapeutics, Inc. (NASDAQ: ALLR) shares fell 11.2% to $0.1278 in pre-market trading. Allarity Therapeutics shares jumped 37% on Monday after the company said it dosed the first patient in its trial studying advanced solid tumors.
- Lichen China Limited (NASDAQ: LICN) fell 11.1% to $1.90 in pre-market trading.
- Gelesis Holdings, Inc. (NASDAQ: GLS) shares fell 9.5% to $0.1900 in pre-market trading after jumping over 90% on Monday.
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or
remove ads
.